Delivery Order SPE2DB20D1047-SPE2DB25FF41E
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,162.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of medical products, including the OMNIPOD 5 DEXG7G6 INTRO(GEN 5)S, a diabetes treatment device. The contract is not set aside and has a period of performance ending on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,790.28, is a Firm Fixed Price Delivery Order for the procurement of OMNIPOD 5 DEXCOM G7 Glucose Monitoring System Pods (Generation 5). The contract has a period of performance through March 17, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,557.74, is for the delivery of OMNIPOD 5 DEXG7G6 INTRO(GEN 5)S medical devices. The contract has a completion date of February 28, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and is an open competition award. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,042.97 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 29, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.47, is for the provision of OMNIPOD 5 DEXG7G6 INTRO(GEN 5)S medical devices. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.31, is for the supply of OMNIPOD 5 DEXG7G6 INTRO (GEN 5)S, a medical device. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,267.60 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 30, 2025. This award is not associated with a set-aside program and is likely part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $15,562.07 Firm Fixed Price Delivery Order, is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,396.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a completion date of March 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,059.15, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...